SPASLER-NEO CARISANO SR CABORIN SPASMOZ SPASMOPRIV GLOVERINE MEBEVER MR COLOFAC ASPA ASPA MEBIPAS MEBIPAS SAMEB MR COLIBAN HUSK-M HUSK-M FACLO COLOSPAS COLOSPAS MEBRIN MEBRIN RAVARINE MEVRIN-135 DESPAS MINSPA ZEESPA MEBRA COLOREST BIOSPA BIOSPA COLORIN MEBSPA TRASPAS NILSPA MEVOREX MEVOREX SPASREX MEBWIN VERGE BERERIN BAVER MESPAREX DANVERIN SPAS-G M.VIRIN BERRIN BERRIN BEVRIN CARAVERIN C-MEB COLONIL MR COLONIL SPASMEB IBSA MEBGHOL MEBGHOL

Dose: 135 to 150 mg
Single Dose: 140 (142.5)
Frequency: 8 hourly
Route: PO
Instructions: 20 mins before meals,

Dose: 25 mg
Single Dose: 25 (25)
Frequency: As recommended.
Route: For 3-4 years
Instructions:

Mebeverine (HCl) is the derivative of Mebeverine. It is of Synthetic origin. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Gastrointestinal Anticholinergics/Antispasmodics and Antispasmodic Agent pharmacological group.The Molecular Weight of Mebeverine is 466.00. Its pKa is 8.1.

Mebeverine

The symptomatic adverse reactions produced by Mebeverine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Anorexia, Insomnia, Allergic reactions, Erythematous rash, Angioedema, Gastrointestinal disturbances, Erythematous rash, dizziness.

Mebeverine is primarily indicated in conditions like Adjunct in GI-disorders, Chronic irritable colon, Gastrointestinal spasm, GIT spasm, Irritable bowel syndrome, Mucous colitis, Spastic colon, Spastic constipation.

No data regarding the interactions of Mebeverine was found.

Drug should not be given to Paediatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store Below 40°C.

Pregnancy and breast-feeding, also avoid in porphyria.Should be used with care in marked hepatic or renal impairment & heart block.